vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and Sea Ltd (SE). Click either name above to swap in a different company.
Sea Ltd is the larger business by last-quarter revenue ($22.9B vs $5.5B, roughly 4.2× Fresenius Medical Care AG). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 7.0%, a 0.9% gap on every dollar of revenue. On growth, Sea Ltd posted the faster year-over-year revenue change (363.4% vs -0.3%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Sea Limited is a tech conglomerate headquartered in Singapore. It is listed on the New York Stock Exchange, with revenue of US$16.8 billion (2024). Sea currently functions as a holding company for Garena, Monee and Shopee, the largest e-commerce platform in Southeast Asia.
FMS vs SE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $22.9B |
| Net Profit | $434.2M | $1.6B |
| Gross Margin | 27.4% | 44.7% |
| Operating Margin | 11.7% | 8.7% |
| Net Margin | 7.9% | 7.0% |
| Revenue YoY | -0.3% | 363.4% |
| Net Profit YoY | 240.4% | — |
| EPS (diluted) | — | $2.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | $22.9B | ||
| Q3 25 | — | $6.0B | ||
| Q2 25 | — | $5.3B | ||
| Q1 25 | — | $4.8B | ||
| Q4 24 | $5.5B | $5.0B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $3.8B | ||
| Q1 24 | — | $3.7B |
| Q4 25 | $434.2M | $1.6B | ||
| Q3 25 | — | $375.0M | ||
| Q2 25 | — | $414.2M | ||
| Q1 25 | — | $-7.8M | ||
| Q4 24 | $127.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-23.0M |
| Q4 25 | 27.4% | 44.7% | ||
| Q3 25 | — | 43.4% | ||
| Q2 25 | — | 45.8% | ||
| Q1 25 | — | 46.2% | ||
| Q4 24 | 25.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 41.6% |
| Q4 25 | 11.7% | 8.7% | ||
| Q3 25 | — | 8.0% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | 9.4% | ||
| Q4 24 | 5.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.9% |
| Q4 25 | 7.9% | 7.0% | ||
| Q3 25 | — | 6.3% | ||
| Q2 25 | — | 7.9% | ||
| Q1 25 | — | -0.2% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.6% |
| Q4 25 | — | $2.52 | ||
| Q3 25 | — | $0.59 | ||
| Q2 25 | — | $0.65 | ||
| Q1 25 | — | $0.65 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $10.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.4B | $12.6B |
| Total Assets | $33.5B | $29.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $10.6B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | $8.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $15.4B | $12.6B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $17.0B | $8.4B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $33.5B | $29.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $36.3B | $22.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | $5.0B |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 6.67× | 3.12× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | $5.0B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | — | $756.9M | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $468.5M |
| Q4 25 | 6.67× | 3.12× | ||
| Q3 25 | — | 9.46× | ||
| Q2 25 | — | 5.73× | ||
| Q1 25 | — | — | ||
| Q4 24 | 20.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
